BREAKING NEWS!!! CEOS PROVIDES CORPORATE UPDATE REGARDING NEW INVESTMENT IN FLUONIC TECHNOLOGY WHICH ESTIMATED TO GROW AT $8.5 BILLION GLOBALLY IN 2017!!
CECORS INC. (OTC: CEOS.PK) - A POTENTIAL 2-3X ROI HERE!!!! Over the past couple days we've been searching for OUR BIGGEST WINNER THIS YEAR and we think we've found the perfect candidate!!! With ONLY 3 MILLION shares in the float, any buying movement WILL CATAPULT CEOS' share price to the orbit!!
CEOS.PK is a newly-traded healthcare company engages in the acquisition and development of healthcare companies for healthcare supplies and healthcare equipment. The company just announced that it has entered into a definitive agreement to acquire a 30% interest in Fluonic, Inc., the developer of the Fluonic technology, its patents and trademarks. The Fluonic technology is extremely exciting and the potential market for these products is enormous, estimated at over $8.5 billion globally for 2017. The Fluonic technology is a medical device, flow monitoring and control system with a primary focus on infusion applications. Fluonic has developed a new generation of disposable infusion device systems that will improve patients’ compliance with safety while reducing costs. The CeCors investment will enable Fluonic to advance its business expansion and the Fluonic technology, including USFDA testing and certification. Concurrently, CEOS management will continue to seek other related healthcare supply companies to bolster current online footprint and expand its operations to National distribution. The seasoned management team has been engaged in healthcare technologies and will continue to develop additional markets through healthcare IT and other related entities. Get in NOW BEFORE THE PUBLIC DISCOVERS THIS HIDDEN GEM!!
3500 Hollywood Blvd.
Hollywood, FL 33021
LATEST NEWS RELEASE: On January 24 CECORS Has Entered into A Definitive Agreement to Acquire 30% Interest in Fluonic, Inc., the Developer of the Fluonic Technology, Its Patents and Trademarks.